Acute Lymphocytic Leukemia Therapeutics Market Size to Surpass Around USD 8.29 Billion by 2032
September 25, 2023 09:42 ET
|
Precedence Research
Ottawa, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The global acute lymphocytic leukaemia therapeutics market was valued at USD 3.12 billion in 2022. Factors such as a rise in the prevalence of acute...
Propulsion of Acute Lymphocytic Leukemia Pipeline as Novel and Extensive 160+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
March 30, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 30, 2023 (GLOBE NEWSWIRE) -- Propulsion of Acute Lymphocytic Leukemia Pipeline as Novel and Extensive 160+ Therapies Likely to Enter in the Treatment Domain | DelveInsight ...
Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market to Reach $3.53 Billion by 2026 at 5.3% CAGR: AMR
September 12, 2019 09:00 ET
|
Allied Market Research
Portland, OR, Sept. 12, 2019 (GLOBE NEWSWIRE) -- According to a report published by Allied Market Research, the global acute lymphocytic/lymphoblastic leukemia therapeutics market was accounted for...